We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.8B
AUM Growth
+$2.12B
Cap. Flow
+$1.31B
Cap. Flow %
8.29%
Top 10 Hldgs %
13.54%
Holding
1,739
New
469
Increased
384
Reduced
350
Closed
529

Sector Composition

Rank Sector Weight
1 Healthcare 19.65%
2 Technology 16.89%
3 Consumer Discretionary 13.55%
4 Industrials 12.67%
5 Financials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALD
751
DELISTED
Callidus Software, Inc.
CALD
$2.44M 0.02%
97,754
-299,188
-75% -$7.28M
KBH icon
752
KB Home
KBH
$3.59B
$2.42M 0.02%
+100,755
New +$2.27M
OC icon
753
Owens Corning
OC
$12.4B
$2.38M 0.02%
30,960
-61,980
-67% -$4.34M
VAR
754
DELISTED
Varian Medical Systems, Inc.
VAR
$2.37M 0.02%
+23,731
New +$2.44M
SAVE
755
DELISTED
Spirit Airlines, Inc.
SAVE
$2.35M 0.01%
71,260
-233,389
-77% -$9.34M
BIO icon
756
Bio-Rad Laboratories Class A
BIO
$9.42B
$2.34M 0.01%
+10,551
New +$2.37M
WCN
757
Waste Connections
WCN
$42B
$2.33M 0.01%
33,298
+25,104
+306% +$1.66M
HBAN icon
758
Huntington Bancshares
HBAN
$35.5B
$2.32M 0.01%
165,423
+147,112
+803% +$1.93M
CPAY icon
759
Corpay
CPAY
$25.7B
$2.31M 0.01%
14,925
-20,605
-58% -$3.02M
EQT icon
760
EQT Corp
EQT
$32.3B
$2.31M 0.01%
+65,322
New +$2.22M
ORBK
761
DELISTED
Orbotech Ltd
ORBK
$2.3M 0.01%
+54,683
New +$2.09M
SABR icon
762
Sabre
SABR
$818M
$2.29M 0.01%
127,493
-44,547
-26% -$865K
BMRN icon
763
BioMarin Pharmaceuticals
BMRN
$12.3B
$2.29M 0.01%
24,657
-227,908
-90% -$20.1M
HPE icon
764
Hewlett Packard
HPE
$70.5B
$2.29M 0.01%
152,823
-38,218
-20% -$521K
PVH icon
765
PVH
PVH
$4.04B
$2.28M 0.01%
18,102
-36,098
-67% -$4.4M
PLCE icon
766
Children's Place
PLCE
$59.8M
$2.28M 0.01%
19,293
-76,105
-80% -$8.19M
LDL
767
DELISTED
Lydall, Inc.
LDL
$2.27M 0.01%
39,918
+28,463
+248% +$1.42M
HDS
768
DELISTED
HD Supply Holdings, Inc.
HDS
$2.27M 0.01%
63,053
-977,276
-94% -$31.4M
LSCC icon
769
Lattice Semiconductor
LSCC
$18.5B
$2.26M 0.01%
+452,673
New +$2.75M
ITGR icon
770
Integer Holdings
ITGR
$4.26B
$2.26M 0.01%
+44,226
New +$2.02M
AMSF icon
771
AMERISAFE
AMSF
$540M
$2.23M 0.01%
38,410
-15,001
-28% -$842K
CC icon
772
Chemours
CC
$2.37B
$2.23M 0.01%
43,681
-71,607
-62% -$3.38M
OMAB icon
773
Grupo Aeroportuario Centro Norte
OMAB
$5.33B
$2.22M 0.01%
50,537
+8,371
+20% +$407K
JBLU icon
774
JetBlue
JBLU
$2.29B
$2.22M 0.01%
+116,609
New +$2.44M
XOG
775
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$2.2M 0.01%
+146,596
New +$1.88M

Similar funds

Marshall Wace North America's Q3 2017 Portfolio in Review

As of Q3 2017, Marshall Wace North America held 1,739 positions worth $15.8B, up 16% from $13.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.31B of net new capital in Q3 2017, opening 469 new positions and adding to 384 existing holdings. Its largest new stake was Delta Air Lines: 1,523,510 shares worth $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Terminix Global Holdings, Inc., an estimated $113M trimmed.

  • Marshall Wace North America's largest Q3 2017 buy was Delta Air Lines: 1,523,510 shares worth $73.1M.
  • Marshall Wace North America added most to Johnson & Johnson in Q3 2017, an estimated $260M increase.
  • Marshall Wace North America's biggest Q3 2017 reduction was Terminix Global Holdings, Inc., cutting an estimated $113M.
  • Marshall Wace North America fully exited Reynolds American Inc in Q3 2017, selling an estimated $130M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $15.8B portfolio in Q3 2017.
  • Marshall Wace North America opened 469 new positions and closed 529 in Q3 2017.
  • Marshall Wace North America's portfolio value rose 16% quarter-over-quarter to $15.8B.

Based on Marshall Wace North America's 13F filing for Q3 2017, filed 13 Nov 2017.